000919 金陵药业
已收盘 10-13 15:00:00
资讯
新帖
简况
金陵药业：截至2026年9月30日，公司股东人数为39,192
证券之星 · 10-12 15:06
金陵药业：截至2026年9月30日，公司股东人数为39,192
股市必读：金陵药业(000919)股东户数3.92万户，较上期增加0.63%
证券之星 · 10-12 04:28
股市必读：金陵药业(000919)股东户数3.92万户，较上期增加0.63%
金陵药业(000919)9月30日股东户数3.92万户，较上期增加0.63%
证券之星 · 10-09
金陵药业(000919)9月30日股东户数3.92万户，较上期增加0.63%
金陵药业：截至2026年9月30日，公司股东人数为39,192
证券之星 · 10-09
金陵药业：截至2026年9月30日，公司股东人数为39,192
股市必读：金陵药业（000919）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：金陵药业（000919）9月24日董秘有最新回复
股市必读：金陵药业新发布《关于控股子公司收到化学原料药上市申请批准通知书的公告》
证券之星 · 09-24
股市必读：金陵药业新发布《关于控股子公司收到化学原料药上市申请批准通知书的公告》
金陵药业(000919)9月20日股东户数3.89万户，较上期减少0.25%
证券之星 · 09-23
金陵药业(000919)9月20日股东户数3.89万户，较上期减少0.25%
金陵药业(000919.SZ)子公司盐酸阿罗洛尔原料药获批上市
智通财经网 · 09-22
金陵药业(000919.SZ)子公司盐酸阿罗洛尔原料药获批上市
金陵药业：截至2026年9月10日，公司股东人数为39,042
证券之星 · 09-15
金陵药业：截至2026年9月10日，公司股东人数为39,042
金陵药业：截至2026年8月31日，公司股东人数为40,300
证券之星 · 09-08
金陵药业：截至2026年8月31日，公司股东人数为40,300
股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》
证券之星 · 09-04
股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》
金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）
证券之星 · 09-03
金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）
金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%
证券之星 · 09-02
金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%
金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升
证券之星 · 08-30
金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
证券之星 · 08-29
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%
智通财经 · 08-28
金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
证券之星 · 08-27
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%
证券之星 · 08-18
金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%
金陵药业：截至2026年8月10日，公司股东人数为40,565
证券之星 · 08-18
金陵药业：截至2026年8月10日，公司股东人数为40,565
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
证券之星 · 08-11
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
暂无数据
公司概况
公司名称：
金陵药业股份有限公司
所属行业：
医药制造业
上市日期：
1999-11-18
主营业务：
金陵药业股份有限公司的主营业务是药品与医疗器械制造、医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。
发行价格：
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":6.58,"timestamp":1791874992000,"preClose":6.53,"halted":0,"volume":11320900,"delay":0,"changeRate":0.0077,"floatShares":622000000,"shares":622000000,"eps":0.09,"marketStatus":"已收盘","change":0.05,"latestTime":"10-13 15:00:00","open":6.5,"high":6.59,"low":6.38,"amount":73426400,"amplitude":0.0322,"askPrice":6.58,"askSize":638,"bidPrice":6.57,"bidSize":212,"shortable":0,"etf":0,"ttmEps":0.09,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.53,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":7.18,"lowLimit":5.88,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":73.111111,"roe":"1.33%","epsLYR":0.0867,"committee":-0.378585,"marketValue":4092000000,"turnoverRate":0.0182,"status":0,"floatMarketCap":4091000000},"requestUrl":"/m/hq/s/000919/tweets","defaultTab":"tweets","newsList":[{"id":"2674824032","title":"金陵药业：截至2026年9月30日，公司股东人数为39,192","url":"https://stock-news.laohu8.com/highlight/detail?id=2674824032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674824032?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:06","pubTimestamp":1791788785,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)10月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截至9月底公司股东人数是多少，谢谢！金陵药业回复：投资者，您好！截至2026年9月30日，公司股东人数为39,192，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674784604","title":"股市必读：金陵药业(000919)股东户数3.92万户，较上期增加0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674784604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674784604?lang=zh_cn&edition=full","pubTime":"2026-10-12 04:28","pubTimestamp":1791750492,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，金陵药业报收于6.67元，上涨2.62%，换手率2.11%，成交量13.09万手，成交额8604.0万元。股本股东变化：截至2026年9月30日，金陵药业股东户数为3.92万户，较9月20日增长0.63%。股本股东变化股东户数变动截至2026年9月30日公司股东户数为3.92万户，较9月20日增加247.0户，增幅为0.63%；户均持股数量由上期的1.6万股减少至1.59万股，户均持股市值为10.31万元。截至2026年9月30日，公司股东人数为39,192，感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674830661","title":"金陵药业(000919)9月30日股东户数3.92万户，较上期增加0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674830661","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674830661?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:32","pubTimestamp":1791538324,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年9月30日公司股东户数为3.92万户，较9月20日增加247.0户，增幅为0.63%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年9月20日至2026年9月30日，金陵药业区间涨幅为0.62%，在此期间股东户数增加247.0户，增幅为0.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900027222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887041","title":"金陵药业：截至2026年9月30日，公司股东人数为39,192","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674887041?lang=zh_cn&edition=full","pubTime":"2026-10-09 11:36","pubTimestamp":1791516979,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至9月30日公司股东人数是多少，谢谢金陵药业回复：投资者，您好！截至2026年9月30日，公司股东人数为39,192，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900015098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409740","title":"股市必读：金陵药业（000919）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409740?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:28","pubTimestamp":1790533693,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，金陵药业报收于6.42元，下跌1.08%，换手率1.15%，成交量7.15万手，成交额4617.08万元。董秘最新回复投资者： 能介绍下公司医康养护服务都有哪些具体开展项目或者服务内容吗？各子公司以所处地区的患者及周边居民为主要服务对象，提供专业化服务，具体开展项目请查看相关单位的官方网站。当日关注点交易信息汇总：9月24日主力资金净流入455.49万元，占总成交额9.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433851","title":"股市必读：金陵药业新发布《关于控股子公司收到化学原料药上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433851","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669433851?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:56","pubTimestamp":1790186176,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，金陵药业报收于6.49元，下跌2.26%，换手率1.61%，成交量10.0万手，成交额6548.21万元。公司公告汇总：控股子公司池州东升药业收到盐酸阿罗洛尔原料药上市申请批准通知书，注册标准编号YBY70782026。股本股东变化股东户数变动截至2026年9月20日公司股东户数为3.89万户，较9月10日减少97.0户，减幅为0.25%；户均持股数量由1.59万股增至1.6万股，户均持股市值为10.32万元。截至2026年9月20日，公司股东人数为38,945，感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104146","title":"金陵药业(000919)9月20日股东户数3.89万户，较上期减少0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104146","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669104146?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:30","pubTimestamp":1790155850,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年9月20日公司股东户数为3.89万户，较9月10日减少97.0户，减幅为0.25%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至9月20日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年9月10日至2026年9月20日，金陵药业区间跌幅为2.71%，在此期间股东户数减少97.0户，减幅为0.25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300029977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124591","title":"金陵药业(000919.SZ)子公司盐酸阿罗洛尔原料药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124591","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669124591?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:15","pubTimestamp":1790064947,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金陵药业(000919.SZ)发布公告，公司控股子公司池州东升药业有限公司近日收到国家药品监督管理局下发的盐酸阿罗洛尔《化学原料药上市申请批准通知书》。盐酸阿罗洛尔是一种同时阻断α和β受体的受体阻断剂，其制剂产品主要用于治疗原发性高血压(轻度至中度)、心绞痛等疾病。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IPOS","BK0239","BK0096","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667961209","title":"金陵药业：截至2026年9月10日，公司股东人数为39,042","url":"https://stock-news.laohu8.com/highlight/detail?id=2667961209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667961209?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:39","pubTimestamp":1789457947,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止9月10日最新股东数是多少？谢谢金陵药业回复：投资者，您好！截至2026年9月10日，公司股东人数为39,042，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500020122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344590","title":"金陵药业：截至2026年8月31日，公司股东人数为40,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665344590?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:33","pubTimestamp":1788838386,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年8月31日股东人数是多少谢谢金陵药业回复：投资者，您好！截至2026年8月31日，公司股东人数为40,300，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800015094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664057898","title":"股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664057898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664057898?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:25","pubTimestamp":1788456312,"startTime":"0","endTime":"0","summary":"公司公告汇总关于更换持续督导保荐代表人的公告金陵药业股份有限公司于2026年9月2日发布公告，因原持续督导保荐代表人王昭辉先生工作变动，中信证券委派邵寅翀先生接替其职务。公司2023年度向特定对象发行A股股票项目的持续督导期虽已于2025年12月31日届满，但因募集资金尚未使用完毕，中信证券将继续履行持续督导义务至募集资金全部使用完毕为止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664470008","title":"金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）","url":"https://stock-news.laohu8.com/highlight/detail?id=2664470008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664470008?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:49","pubTimestamp":1788396546,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司外延并购有没有进展金陵药业回复：投资者，您好，感谢您对公司的关注。公司已于 2026 年 4 月 14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021），该事项目前仍处于意向阶段。后续若出现达到披露标准的实质性进展或重大变化，公司将及时履行信息披露义务，敬请注意投资风险，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300007836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664172738","title":"金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664172738","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664172738?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:25","pubTimestamp":1788359121,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，金陵药业报收于6.7元，较前一交易日下跌2.33%，最新总市值为41.67亿元。近日，金陵药业股份有限公司发布公告称，因原持续督导保荐代表人王昭辉先生工作变动，中信证券委派邵寅翀先生接替其职务。公司2023年度向特定对象发行A股股票项目的持续督导期虽已于2025年12月31日届满，但因募集资金尚未使用完毕，中信证券将继续履行持续督导义务至募集资金全部使用完毕为止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663704825","title":"金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663704825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663704825?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:21","pubTimestamp":1788042105,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金陵药业发布2026年中报。截至本报告期末，公司营业总收入15.84亿元，同比下降1.04%，归母净利润5038.25万元，同比上升4.24%。按单季度数据看，第二季度营业总收入8.16亿元，同比上升3.12%，第二季度归母净利润2237.93万元，同比下降11.72%。本报告期金陵药业盈利能力上升，毛利率同比增幅15.14%，净利率同比增幅12.2%。去年的净利率为1.6%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012640","title":"金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012640","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012640?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:12","pubTimestamp":1787994774,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月20日公司股东户数为4.27万户，较8月10日增加2124.0户，增幅为5.24%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，金陵药业区间涨幅为7.14%，在此期间股东户数增加2124.0户，增幅为5.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009669","title":"金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009669","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662009669?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:47","pubTimestamp":1787924835,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金陵药业 发布2026年半年度报告，报告期内，公司实现营业收入15.84亿元，同比下降1.04%;归属于上市公司股东的净利润5038.25万元，同比增长4.24%;归属于上市公司股东的扣除非经常性损益的净利润4891.28万元，同比增长37.74%;基本每股收益0.081元。报告期内，公司“医药工业和医康养护”双平台同步攻坚、协同发力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703543","title":"金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703543?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:04","pubTimestamp":1787825097,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月20日公司股东户数为4.27万户，较8月10日增加2124.0户，增幅为5.24%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，金陵药业区间涨幅为7.14%，在此期间股东户数增加2124.0户，增幅为5.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465193","title":"金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465193?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:28","pubTimestamp":1787045300,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月10日公司股东户数为4.06万户，较7月31日增加22.0户，增幅为0.05%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年7月31日至2026年8月10日，金陵药业区间涨幅为4.61%，在此期间股东户数增加22.0户，增幅为0.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660409459","title":"金陵药业：截至2026年8月10日，公司股东人数为40,565","url":"https://stock-news.laohu8.com/highlight/detail?id=2660409459","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660409459?lang=zh_cn&edition=full","pubTime":"2026-08-18 11:33","pubTimestamp":1787023990,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止8月10号，公司的股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2026年8月10日，公司股东人数为40,565，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800016043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","000919","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658964319","title":"金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658964319","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658964319?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:29","pubTimestamp":1786440551,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年7月31日公司股东户数为4.05万户，较7月20日减少1221.0户，减幅为2.92%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月20日至2026年7月31日，金陵药业区间涨幅为0.32%，在此期间股东户数减少1221.0户，减幅为2.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791921573801,"stockEarnings":[{"period":"1week","weight":0.0123},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0123},{"period":"6month","weight":-0.1942},{"period":"1year","weight":-0.0223},{"period":"ytd","weight":-0.1588}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39192人(较上一季度增加0.63%)","perCapita":"15863股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品与医疗器械制造、医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}